| pubmed-article:20160062 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0239307 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0035168 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C1335110 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0006118 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C1415877 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0205618 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C1415876 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:20160062 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:20160062 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:20160062 | pubmed:dateCreated | 2010-3-2 | lld:pubmed |
| pubmed-article:20160062 | pubmed:abstractText | Recent studies have shown the prognostic significance of IDH1 mutations in glioma. It is yet unclear if IDH1 mutations are predictive for outcome to chemotherapy. We determined the effect of IDH1 mutations on progression-free survival and overall survival (OS), and its correlation with other clinical and molecular features in the prospective randomized European Organization for Research and Treatment of Cancer study 26951 on adjuvant procarbazine, 1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea, and vincristine (PCV) in anaplastic oligodendroglioma. | lld:pubmed |
| pubmed-article:20160062 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20160062 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20160062 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20160062 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20160062 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:FrenayMarcM | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:WesselingPiet... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:DinjensWinand... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:SansonMarcM | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:KrosJohan MJM | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:TijssenCees... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:BrandesAlba... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:TaphoornMarti... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:GorliaThierry... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:MarieYannickY | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:van den... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:DubbinkHendri... | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:LacombeDenisD | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:IdbaihAhmedA | lld:pubmed |
| pubmed-article:20160062 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:20160062 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20160062 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:20160062 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:20160062 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20160062 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20160062 | pubmed:pagination | 1597-604 | lld:pubmed |
| pubmed-article:20160062 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:meshHeading | pubmed-meshheading:20160062... | lld:pubmed |
| pubmed-article:20160062 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20160062 | pubmed:articleTitle | IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. | lld:pubmed |
| pubmed-article:20160062 | pubmed:affiliation | Dept Neuro-Oncology and Pathology, Daniel den Hoed Cancer Center and Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands. m.vandenbent@erasmusmc.nl | lld:pubmed |
| pubmed-article:20160062 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20160062 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20160062 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20160062 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:20160062 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| entrez-gene:3417 | entrezgene:pubmed | pubmed-article:20160062 | lld:entrezgene |
| entrez-gene:3418 | entrezgene:pubmed | pubmed-article:20160062 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20160062 | lld:entrezgene |
